返回
When increased bone marrow blasts may not mean malignancy
DOI:10.1182/blood.2025029542.png)
摘要
En
期刊
IF:
23.1
论文数:
5.5K
被引数:
16.6W
机构
暂无机构信息
引用论文
ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis
HAEMATOLOGICA
IF7.9
Inherited thrombocytopenia caused by ANKRD26 mutations misdiagnosed and treated as myelodysplastic syndrome: report on two casesANKRD26基因突变致遗传性血小板减少症误诊为骨髓增生异常综合征2例
Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families
Blood
IF0
Hereditary platelet disorders associated with germ line variants in RUNX1, ETV6, and ANKRD26
Blood
IF0
Wahlster L, Godley L, Cheng J, et al. ANKRD26-related thrombocytopenia-2 with a baseline increase in blasts: implications for clinical surveillance. Blood. 2025 blood.2024027368, (accepted paper).Wahlster L,Godley L,Cheng J,等。ANKRD26相关的血小板减少症-2伴有基线原始细胞增多:对临床监测的启示。Blood. 2025 blood.2024027368,(已接受论文)。
没有更多内容

